Literature DB >> 27604618

Vaccines and multiple sclerosis: a systematic review.

Mia Topsøe Mailand1, Jette Lautrup Frederiksen2.   

Abstract

Vaccinations are often the most effective tool against some disease known to mankind. This study offers a literature review on the role of vaccines regarding the risk of developing multiple sclerosis (MS) and MS relapse. The method used in this study is a systematic literature review on the database PubMed. The study found no change in risk of developing multiple sclerosis (MS) after vaccination against hepatitis B virus, human papillomavirus, seasonal influenza, measles-mumps-rubella, variola, tetanus, Bacillus Calmette-Guérin (BCG), polio, or diphtheria. No change in risk of relapse was found for influenza. Further research is needed for the potential therapeutic use of the BCG vaccine in patients in risk of developing MS and for the preventive potential of the tetanus and diphtheria vaccine.

Entities:  

Keywords:  Immunization; Multiple sclerosis; Vaccination

Mesh：

Year:  2016        PMID： 27604618     DOI： 10.1007/s00415-016-8263-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   6.682


  62 in total

Review 1.  Vaccinations and multiple sclerosis.

Authors:  O Gout
Journal:  Neurol Sci       Date:  2001-04       Impact factor: 3.307

2.  Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination.

Authors:  Vitali Pool; Daniel M Gordon; Michael Decker
Journal:  Arch Neurol       Date:  2012-01

3.  H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study.

Authors:  Mauricio F Farez; María C Ysrraelit; Marcela Fiol; Jorge Correale
Journal:  Mult Scler       Date:  2011-08-09       Impact factor: 6.312

4.  Risk factors for multiple sclerosis: a case-control study in Israel.

Authors:  N Zilber; E Kahana
Journal:  Acta Neurol Scand       Date:  1996-12       Impact factor: 3.209

5.  School-based hepatitis B vaccination programme and adolescent multiple sclerosis.

Authors:  A D Sadovnick; D W Scheifele
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

6.  Vaccinations and risk of central nervous system demyelinating diseases in adults.

Authors:  Frank DeStefano; Thomas Verstraeten; Lisa A Jackson; Catherine A Okoro; Patti Benson; Steven B Black; Henry R Shinefield; John P Mullooly; William Likosky; Robert T Chen
Journal:  Arch Neurol       Date:  2003-04

7.  Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination.

Authors:  M Salvetti; A Pisani; S Bastianello; E Millefiorini; C Buttinelli; C Pozzilli
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

8.  Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis.

Authors:  J De Keyser; C Zwanikken; M Boon
Journal:  J Neurol Sci       Date:  1998-07-15       Impact factor: 3.181

9.  Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

Authors:  Giovanni Ristori; Silvia Romano; Stefania Cannoni; Andrea Visconti; Emanuele Tinelli; Laura Mendozzi; Pietro Cecconi; Roberta Lanzillo; Mario Quarantelli; Carla Buttinelli; Claudio Gasperini; Marco Frontoni; Giulia Coarelli; Domenico Caputo; Vincenzo Bresciamorra; Nicola Vanacore; Carlo Pozzilli; Marco Salvetti
Journal:  Neurology       Date:  2013-12-04       Impact factor: 9.910

10.  Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis.

Authors:  Yann Mikaeloff; Guillaume Caridade; Mélanie Rossier; Samy Suissa; Marc Tardieu
Journal:  Arch Pediatr Adolesc Med       Date:  2007-12
View more
  31 in total

Review 1.  [Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]

Authors:  M Löbermann; B Handorn; A Winkelmann; E C Reisinger; H P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

2. 

Authors:  Norbert Wagner; Frauke Assmus; Gabriele Arendt; Erika Baum; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Dirk Föll; Edeltraut Garbe; Jane Hecht; Ulf Müller-Ladner; Tim Niehues; Klaus Überla; Sabine Vygen-Bonnet; Thomas Weinke; Miriam Wiese-Posselt; Michael Wojcinski; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

3.  Vaccine Hesitancy and Illness Perceptions: Comparing Parents of Children with Autism Spectrum Disorder to other Parent Groups.

Authors:  Leila C Sahni; Julie A Boom; Sarah S Mire; Leandra N Berry; Lauren R Dowell; Charles G Minard; Rachel M Cunningham; Robin P Goin-Kochel
Journal:  Child Health Care       Date:  2020-03-17

Review 4.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

5.  Negative perceptions of hepatitis B vaccination among attendees of an urban free testing center for sexually transmitted infections in France.

Authors:  Lauranne Moyroud; Sarah Hustache; Laurence Goirand; Marianne Hauzanneau; Olivier Epaulard
Journal:  Hum Vaccin Immunother       Date:  2016-12-12       Impact factor: 3.452

Review 6.  Infections of the Central Nervous System in Returning Travelers and Immigrants.

Authors:  Haley Thompson; Kiran Thakur
Journal:  Curr Infect Dis Rep       Date:  2017-10-03       Impact factor: 3.725

7.  Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies.

Authors:  Christoph Metze; Alexander Winkelmann; Micha Loebermann; Michael Hecker; Brunhilde Schweiger; Emil Christian Reisinger; Uwe Klaus Zettl
Journal:  CNS Neurosci Ther       Date:  2018-07-25       Impact factor: 5.243

8.  Case Report: Postvaccination Anti-Myelin Oligodendrocyte Glycoprotein Neuromyelitis Optica Spectrum Disorder: A Case Report and Literature Review of Postvaccination Demyelination.

Authors:  Neha Kumar; Kelsey Graven; Nancy I Joseph; John Johnson; Scott Fulton; Robert Hostoffer; Hesham Abboud
Journal:  Int J MS Care       Date:  2020 Mar-Apr

Review 9.  Advancements in protein nanoparticle vaccine platforms to combat infectious disease.

Authors:  Nina Butkovich; Enya Li; Aaron Ramirez; Amanda M Burkhardt; Szu-Wen Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-08

10.  COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.

Authors:  Anat Achiron; Mark Dolev; Shay Menascu; Daniela-Noa Zohar; Sapir Dreyer-Alster; Shmuel Miron; Emanuel Shirbint; David Magalashvili; Shlomo Flechter; Uri Givon; Diana Guber; Yael Stern; Michael Polliack; Rina Falb; Michael Gurevich
Journal:  Mult Scler       Date:  2021-04-15       Impact factor: 6.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.